Daxor’s blood volume analysis diagnostic reaches two new U.S. healthcare systems
May 14, 2025
Daxor Corporation announced the expansion of its diagnostic solutions into two additional U.S. healthcare systems.
This strategic expansion includes:
- A premier regional referral center in East Tennessee has integrated Daxor’s advanced ezBVA Lab service into its cardiology practice. The CLIA-certified laboratory service, based in Tennessee, leverages state-of-the-art BVA technology-based analysis to deliver comprehensive diagnostic results within 24 hours, enhancing precision care for outpatient cardiology services.
- A leading comprehensive healthcare facility in the Pacific Northwest has implemented Daxor’s on-site BVA analyzer system. This installation supports both inpatient and outpatient diagnostic needs across cardiology and intensive care departments, enabling immediate access to critical blood volume data that drives clinical decision-making.
The ezBVA Lab service and on-site BVA analyzers utilize Daxor’s proprietary technology to deliver gold-standard blood volume measurements, empowering clinicians with actionable diagnostic insights that have been clinically proven to reduce mortality, hospital readmissions and length of stay when managing heart failure and other critical conditions.
